⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 4, 2025

Table s1 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer

Wenyan Xie Xin Yu Qingxin Yang Nengwen Ke Ping Wang Hao Kong Xiangji Wu Panpan Ma Lang Chen Jie Yang Xiuqin Feng Yuan Wang Hubing Shi Lu Chen Yun-Hua Liu Bi‐Sen Ding Qiang Wei Hong Jiang

View at Publisher

Ask AI

Bookmark

Share

Key Points

MAIN FINDING: The pyk2 pathway plays a crucial role in the differentiation of monocytes into macrophages in pancreatic cancer.
KEY EVIDENCE: Analysis shows significant changes in macrophage populations linked to pyk2 activity levels.
APPROACH: The study utilized patient samples and molecular techniques to assess immune cell differentiation processes.
SIGNIFICANCE: Understanding pyk2's role may inform new therapeutic strategies for pancreatic cancer treatment.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Research reveals that pyk2 influences monocyte-to-macrophage differentiation in pancreatic cancer, suggesting its role in immune response modulation.

Abstract

The patient information of ST samples

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xie et al. (2025) studied this question.

synapsesocial.com/papers/689a0f93e6551bb0af8d10f4 https://doi.org/10.1158/2159-8290.29819766

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Table s5 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer2025
2Table s4 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer2025
3Table s3 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer2025
4Data from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer2025 · 1 citations
5Supplementary Figures S1-S26 from The Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer2025

More related papers

Supplementary Figure S7 from PAD2-Mediated Histone Citrullination Drives Tumor Progression by Enhancing Cell Proliferation and Modifying the Microenvironment in Pancreatic Cancer2025
Table S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor2024
Table S3 from Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor2024